OraSure Technologies
OraSure Stock Ticks Up on Rumor of Declined Quidel Acquisition Offer
The firm's stock price rose as much as nearly 12 percent on Monday following a report saying that it had rejected a takeover bid from Quidel.
OraSure Technologies Q1 Revenues Jump 85 Percent
The firm announced that it has submitted a COVID-19 antigen test for Emergency Use Authorization review by the US Food and Drug Administration.
OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate
The firm attributed its quarterly and annual revenue gains primarily to sales of COVID-19 testing sample collection devices.
OraSure Saliva Collection Device Gets Canada Authorization for COVID-19 Testing
The device also has Emergency Use Authorization from the US Food and Drug Administration and has CE marking for in vitro diagnostic use.
DNA Genotek Gets FDA Emergency Use Authorization for Saliva Collection Devices
The saliva collection devices are designed for use with third-party SARS-CoV-2 tests or home/self-collection kits and are not intended for sale to patients.
May 6, 2020
OraSure Technologies Q1 Revenues Rise 5 Percent
Feb 19, 2020
OraSure Technologies Q4 Revenues Down 1 Percent
Jan 22, 2020
Nov 7, 2019
Aug 23, 2019